Device Trial Radar · NCT04547920
FREEOAB Study for Overactive Bladder
Last checked: Nov 20, 2026Latest source record: Feb 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Jan 11, 2021
Primary completion
Oct 8, 2021
Study completion Jun 15, 2023
Sponsor
- Lead sponsor
- Avation Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 14, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multicenter study that was conducted to evaluate the safety and efficacy of a novel, closed-loop, continuous-sensing wearable neuromodulation system for Overactive Bladder symptom control.
Conditions
- Overactive Bladder
- Urinary Frequency
- Urinary Incontinence, Urge
- Urinary Urgency
Interventions
Wearable Bladder Modulation SystemDevice
Wearable Closed-Loop, Continuous Sensing Tibial Nerve Stimulation Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Responders in Voiding (Urinary Frequency) EventsTime frame: 12 Weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Stanford, California
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.